http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2641188-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9433d383d1922b3df0ca6c182c7d3925
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2989
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5015
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
filingDate 1989-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9df8fb5ede7776b60d8202b96d9405b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_467ee53a0677669cd83b1c4ba138bbb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_078c0aa81c501a349e6fb5f5bac0c08b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c8c8eea9a0344b5277babbb4d163aad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2685b1d820bfa534193da77635913751
publicationDate 1990-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2641188-A1
titleOfInvention PROCESS FOR PREPARING MICROCAPSULES FOR FAST RELEASE OF A MEDICINAL PRODUCT AS AN ACTIVE INGREDIENT
abstract The invention relates to a method for the preparation of microcapsules providing direct compression of a drug into tablets and rapid release of the drug as an active ingredient from the tablets, which comprises microencapsulating the crystalline granules of insoluble active ingredients. in cyclohexane having a particle size equal to at most 1000 mum, preferably less than 60 mum and more preferably less than 30 mum, in a cyclohexane-based medium with ethylcellulose admitted in an amount of 1:30 at 1:15, preferably 1:20 to 1:10, based on the core substance, if desired, in the presence of 0.001 to 1.0% w / v, preferably 0.01 to 0.05% by weight / volume, of an anionic surfactant; or post-treating the microencapsulated drug granules with ethylcellulose with a surfactant dissolved in cyclohexane and admitted in an amount of 0.001 to 1.0% w / v, preferably 0.1 to 0, 5% w / v, based on cyclohexane.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-742009-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9952510-A1
priorityDate 1988-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0076515-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID236409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7852
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411985344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530015
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421451617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID38853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414877360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416150250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407981510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411174056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453628025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409702108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415893423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454479250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449628176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19905501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62815
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9020

Total number of triples: 66.